More on CXM
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net loss | -3.24M |
| Gain on sale of discontinued operation | |
| Gain on sale of warrants | |
| Loss on abandonment of leaseholds | |
| Depreciation | 7.68K |
| Amortization-intangibles | |
| Amortization-debt discount | |
| Amortization-deferred financing costs | |
| Amortization-technology and product license fee | |
| Provision for obsolete inventory | 0 |
| Change in fair value of warrants | |
| Common stock and warrants issued for services and reimbursement of expenses | |
| Stock based compensation expense | 961.22K |
| In-process purchased technology | |
| Accounts receivable | |
| Inventories | |
| Prepaid expenses and other assets | 183.13K |
| Deposits | |
| Accounts payable | 416.98K |
| Accrued liabilities | 432.67K |
| Deferred rent | |
| Net cash used in operating activities | |
| In-process technology purchased from Tissue Repair Company | |
| Fee paid to list shares issued for technology and product license | |
| Purchases of property and equipment | |
| Net cash used in investing activities | |
| Proceeds from officer loan | |
| Cash acquired in acquisitions | |
| Restricted cash - collateral for letter of credit | |
| Restricted cash - proceeds placed in escrow from sale of business | |
| Proceeds from the exercise of warrants, net | |
| Proceeds from debt financing agreement, net of debt issuance costs of $871,833 | |
| Proceeds from the sale of business unit | |
| Repayment of debt | |
| Proceeds from sales of common stock, net of issuance cost | 600K |
| Net cash provided by financing activities | |
| Net increase (decrease) in cash | -198.52K |
| Cash and cash equivalents at beginning of period | 216.73K |
| Cash and cash equivalents at end of period | 18.22K |
| Cash paid for interest | 4.49K |
| Cash paid for income taxes | |
| Subscription receivable for common shares | |
| Common stock issued for repayment of loans | |
| Stock issued for technology license fee | |
| Net assets acquired for the issuance of common stock (exclusive of cash acquired) | |
| Warrants exchanged for stock | |
| Reclassification of derivative liabilities with expired price protection provisions | |
| Issuance of note for accrued milestone payment | |
Entities mentioned with CXM
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Citi | View Related Stories »
- Definitive Agreement | View Related Stories »
- IPO | View Related Stories »
- Show More...
